"Core Stabilization Strenght and Pelvic Floor Functions in Primary Sjogren's"
Launched by PAMUKKALE UNIVERSITY · Mar 13, 2025
Trial Information
Current as of May 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- Sjogren syndrome group:
- • Diagnosed by a rheumatologist
- • Being 18 years of age or older,
- • Agreeing to participate in the study
- Control group:
- • -Being 18 years of age or older,
- Exclusion Criteria:
- Sjogren syndrome group and control group:
- • Presence of neurological disease
- • Presence of any orthopedic problem that would affect functionality
- • Presence of a history of orthopedic surgery
About Pamukkale University
Pamukkale University is a renowned academic institution located in Denizli, Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the broader scientific community. With a commitment to ethical standards and regulatory compliance, Pamukkale University fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring the rigorous execution of clinical trials that address critical health challenges. Through its research initiatives, the university aims to enhance the understanding of various medical conditions and support the development of effective therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Denizli, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported